Dealing With Enlarged Prostate
Enlarged prostate, also known as Benign Prostatic Hyperplasia (BPH) is a common condition that can be embarrassing and negatively affects your quality of life.
The goal of the UroLift® System procedure is to relieve symptoms so you can get back to your life and resume your daily activities.
The UroLift® System is the only leading procedure for BPH that does not require heating, cutting, removal, or destruction of prostate tissue. The UroLift® System is a proven option for patients looking for an alternative to medications or major surgery.1
1. Roehrborn, Can J Urol 2017
Southeast Valley Urology Understands
You don’t deserve to be embarrassed or live with a condition that negatively affects your quality of life. Southeast Valley Urology is dedicated to leading the way in urological care in Gilbert, Arizona by putting the patient at the center of our practice. We serve you by utilizing leading technology to best diagnose and treat your conditions.
About Southeast Valley Urology
Our specialist, Dr. Frank L. Simoncini, sees patients in Gilbert, AZ
Contact us now for an appointment.
Dr. Frank L. Simoncini
is originally from Whittier, CA. He earned his medical degree from the College of Osteopathic Medicine of the Pacific in Pomona, CA. Dr. Simoncini has been practicing at Southeast Valley Urology since 1996.
Locations:
Southeast Valley Urology
1501 North Gilbert Road, Suite 204
Gilbert, AZ 85234
Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men get older. BPH is a very common condition that affects about 42 million men in the US1 and over 660 million aging men worldwide.2,3 Over 40% of men in their 50s and over 70% of men in their 60s have BPH.2 While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man’s quality of life.
As the prostate enlarges, it presses on and blocks the urethra, causing bothersome urinary symptoms. If left untreated, BPH can lead to permanent bladder damage.4
Symptoms include: 5,6
- Frequent need to urinate both day and night
- A sense that you cannot completely empty your bladder
- Urgent feeling of needing to urinate
- Weak or slow urine stream
- Difficulty or delay in starting urination
- A urinary stream that stops and starts
Symptoms of BPH can cause loss of productivity, depression, and decreased quality of life.7
If you suffer from the above symptoms, you are not alone. BPH is the leading reason men visit a urologist.8
You can measure your BPH symptoms by taking the International Prostate Symptom Score (IPSS) questionnaire. Sharing this information with your physician will help them understand the severity of your symptoms.
1. U.S. 2022 estimates based on US Market Model 2022-24 (5-17-22FINAL), which is in part based on data provided by Symphony HealthPatientSource® data. This information is provided as is and Symphony Health makes no representations or warranties of any kind, including with respect to accuracy or completeness. PatientSource is a trademark of Symphony Health.
2. Berry, et al., Journal of Urology 1984
3. US Census Bureau international database worldwide population estimates for 2020
4. Tubaro, Drugs Aging 2003
5. Rosenberg, Int J Clin Pract 2007
6. Vuichoud, Can J Urol 2015
7. Speakman, BJUI International 2014
8. IMS Health NDTI Urology Specialty Profile Report 2013
What is the UroLift® System?
The UroLift® System is a proven minimally invasive procedure to treat an enlarged prostate. It is the only leading enlarged prostate procedure that does not require heating, cutting, removal, or destruction of prostate tissue. The procedure is typically performed as a same-day outpatient procedure, including the office setting, under local anesthesia.1
Advantages of the UroLift® System
- Safe and Effective 2
- Risk profile better than those reported for surgical procedures such as TURP 3
- Rapid symptom relief 4, better than reported for medications 5
- Only leading BPH procedure shown not to cause new and lasting sexual dysfunction *2,5,6
- Covered by Medicare, national, and commercial plans, when medical criteria are met
- Typically no catheter is required after treatment 4,6 feeling of needing to urinate
How does The UroLift® System Work?
Step 1
The UroLift® Delivery Device is placed through the obstructed urethra to access the enlarged prostate.
Step 2
Small UroLift® Implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.
Step 3
The UroLift® Delivery Device is removed, leaving an open urethra designed to provide relief.
*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T pivotal study
Indicated for the treatment of symptoms of an enlarged prostate up to 100 cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and/or the inability to control the urge.4 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Speak with your doctor to determine if you may be a candidate.
1. Shore, Can J Urol 2014
2. Roehrborn, Can J Urol 2017
3. Sonksen, EU J Urol, 2015
4. Roehrborn, J Urology 2013
5. AUA BPH Guidelines 2003, 2020
6. MvVary, J Sex Med 2016
Hear from patients who chose the UroLift® System
Dwight shares his story.
Ken W. shares his story.
John M. shares his story.
Bladder Disease Progression
Even watchful waiting has its risks. Bladder outlet obstruction could result in irreversible bladder damage if left untreated.1
1. Tubaro, Drug Aging 2003
If you have been diagnosed with an enlarged prostate due to BPH, consult with
your physician to determine which treatment is right for you.
Treatment options may include:
Rezum and GreenLight are trademarks of Boston Scientific. Aquablation is a trademark of PROCEPT BioRobotics Corp.
1. AUA BPH Guidelines 2003. Updated 2010.
2. Djavan, Urology 2004
3. Chang DF, Campbell JR, J Cataract Refract Surg. 2005
4. Duan et al, Pharmacoepidemiol Drug Saf. 2018
5. Welk et al, JAMA Intern Med. 2017
6. Roehrborn, J Urol 2013
7. Roehrborn, Can J Urol 2017
8. Shore Can J Urol 2014
9. Tutrone, Can J Urol 2020
10. Eure, et al., AUA 2020
11. Sonksen, et al., Eur Urol 2015
12. McVary, J Urol 2016
13. McVary, J Urol 2020; AUA abstract LBA01-06 5-year Rezum